Evidence map›Paper›PMID 41460962›Full record

ArticleBlood2026

Enterococcus faecalis induces MHC-II expression by the intestinal epithelium during murine graft-versus-host disease.

Chi L Nguyen, Jennifer Funes, Romina Ghale, Nathan Duong, Kristen Victor, Brianna Gipson, Zhenrun J Zhang, Anqi Dai, Rita Li, Gabriel Armijo and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Blood, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07791849 (Comparative Effect of Proton Pump Inhibitors and Gastric Mucosal Protective Agents on Acute Graft-versus-Host Disease Post-Transplantation), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07791849 narecruitingnot on this map

Comparative Effect of Proton Pump Inhibitors and Gastric Mucosal Protective Agents on Acute Graft-versus-Host Disease Post-Transplantation: A Prospective Randomized Controlled Trial

TypeinterventionalSponsorFirst Affiliated Hospital of Zhejiang UniversityRan2026 to 2028Enrolled198ConditionsHematopoietic Stem Cell Transplantation (HSCT), aGVHD, Infection, MortalityArmsTeprenone, Esomeprazole
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Chi L NguyenDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.
Jennifer FunesBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.
Romina GhaleDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.
Nathan DuongBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.
Kristen VictorDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0009-0000-7948-3698
Brianna GipsonDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0009-0005-5837-8676
Zhenrun J ZhangBiological Sciences Division, Duchossois Family Institute, University of Chicago, Chicago, IL.
Anqi DaiDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0003-3106-4624
Rita LiBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0009-0006-0320-9231
Gabriel ArmijoDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-7930-8248
Ashley HuangBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.
Miriam MartinezBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.
Yuqing ChenBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0003-0649-530X
Daniel GhazarianBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0009-0008-7479-2289
Melissa DocampoDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.
Khyatiben PathakIntegrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, CA.
Patrick PirrotteIntegrated Mass Spectrometry Shared Resource, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0003-1360-6039
Kate A MarkeyTranslational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-7064-2362
Jonathan U PeledAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-4029-7625
Jenny ParedesBeckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0009-0004-9341-0187
Marina Burgos da SilvaDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0001-8630-7211
Marcel R M van den BrinkDepartment of Immunology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
T LYMPHOCYTE SUBSET FUNCTION POST-TRANSPLANTATIONP01CA023766 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PERALES, MIGUEL-ANGEL · 1985 to 2023
$59.0M
Thymic and Peripheral Aspects of T Cell Aging and RejuvenationP01AG052359 · NIA · UNIVERSITY OF ARIZONA · PI Lauren Ilyse Richie EHRLICH · 2017 to 2026
$23.5M
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant PathogensU01AI124275 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI PAMER, ERIC G., XAVIER, JOAO · 2016 to 2020
$8.9M
The role of intestinal microbiota in graft-versus-host diseaseR01CA228308 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Philip L Lorenzi, Marcel R M van den Brink · 2018 to 2026
$5.2M
The role of autophagy gene Atg16L1 in allogeneic hematopoietic stem cell transplantation - Resubmission - 1R01HL123340 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CADWELL, KEN HASHIGIWA, VAN DEN BRINK, MARCEL R M · 2015 to 2022
$5.2M
Regulation of the intestinal stem cell compartment after hematopoietic transplantationR01HL125571 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI Alan M Hanash · 2015 to 2026
$4.4M
The role of the intestinal microbiome in cancer immunotherapyR35CA284024 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Marcel R M van den Brink · 2023 to 2026
$4.2M
The role of intestinal microbiota in graft-versus-host diseaseR01CA228358 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI VAN DEN BRINK, MARCEL R M · 2018 to 2022
$2.6M
Microbiota mechanisms and biomarkers in GVHDK08HL143189 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI PELED, JONATHAN · 2019 to 2023
$858k
NCI NIH HHS P01 CA023766NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA228308NCI NIH HHS R01 CA228358NCI NIH HHS R35 CA284024NHLBI NIH HHS K08 HL143189NHLBI NIH HHS R01 HL123340NHLBI NIH HHS R01 HL125571NIAID NIH HHS U01 AI124275NIA NIH HHS P01 AG052359
6 · The paper itself

Abstract

abstractIntestinal Enterococcus domination has been associated with an increased risk of mortality from acute graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (allo-HCT), a curative-intent treatment for patients with hematologic malignancies. In this study, we investigated interactions between Enterococcus and the intestinal epithelium as a mechanism to aggravate GVHD. We observed that endogenous intestinal Enterococcus outgrowth was associated with increased GVHD mortality and major histocompatibility complex class II (MHC-II) expression by intestinal epithelial cells in the colon in an MHC-disparate mouse model of GVHD. Monocolonization of nontransplanted gnotobiotic mice with Enterococcus faecalis was sufficient to induce colonic MHC-II expression. Conversely, select species within the genus Enterococcus, as well as a consortium of 4 anaerobic commensal bacteria including Blautia producta, did not affect colonic MHC-II expression in gnotobiotic mice. In addition, E faecalis colonization induced inflammatory responses in CD4+ T cells and natural killer cells from the colonic lamina propria, the 2 main sources of interferon gamma production that drives MHC-II expression in nonprofessional antigen-presenting cells. We further explored the potential therapeutic benefit of establishing colonization resistance against E faecalis through administration of a lantibiotic-producing B producta strain after allo-HCT. Colonization of transplanted mice with a consortium of commensal bacteria containing the lantibiotic-producing B producta strain prevented intestinal Enterococcus domination after transplantation and improved GVHD survival. Our results demonstrate a potential mechanism by which Enterococcus aggravates GVHD through increased MHC-II expression in the intestinal epithelium. Targeting the Enterococcus-epithelium-MHC-II axis thus presents a therapeutic opportunity to prevent lethal GVHD.

Indexed as

Enterococcus faecalisGraft vs Host DiseaseHistocompatibility Antigens Class IIIntestinal MucosaAnimalsCD4-Positive T-LymphocytesDisease Models, AnimalFemaleGerm-Free LifeHematopoietic Stem Cell TransplantationKiller Cells, NaturalMiceMice, Inbred C57BLHistocompatibility Antigens Class II

Identifiers

PMID41460962
PMCPMC13077440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.